Bioavailability and relative tissue distribution of [125I]-recombinant human thrombin following intravenous or subcutaneous administration to non-human primates
Bioavailability; Recombinant human thrombin; Tissue distribution
Indexed keywords
ANTITHROMBIN III;
THROMBIN I 125;
THROMBIN INHIBITOR;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
AREA UNDER THE CURVE;
ARTICLE;
BLOOD ANALYSIS;
COMPLEX FORMATION;
CONTROLLED STUDY;
DRUG BINDING;
DRUG BIOAVAILABILITY;
DRUG CLEARANCE;
DRUG DETERMINATION;
DRUG DISTRIBUTION;
DRUG ELIMINATION;
DRUG HALF LIFE;
DRUG TISSUE LEVEL;
GAMMA RADIATION;
GEL PERMEATION CHROMATOGRAPHY;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
MALE;
MONKEY;
NONHUMAN;
PRIMATE;
PRIORITY JOURNAL;
QUANTITATIVE ANALYSIS;
RADIOACTIVITY;
SYSTEMIC CIRCULATION;
TISSUE DISTRIBUTION;
WHOLE BODY SCINTISCANNING;
Absorption and elimination of alpha-thrombin and tranexamic acid after fibrin sealant application on resected livers in rabbits
Nur I, Routledge L, Lushkov G, Paulmier P, Virat M. Absorption and elimination of alpha-thrombin and tranexamic acid after fibrin sealant application on resected livers in rabbits. Blood Coagul Fibrinolysis 1998; 9: 533-7.
The isolation and characterization of a specific antibody population directed against the thrombin antithrombin complex
Lau HK, Rosenberg RD. The isolation and characterization of a specific antibody population directed against the thrombin antithrombin complex. J Biol Chem 1980; 255: 5885-93.
Clearance of thrombin from circulation in rabbits by high-affinity binding sites on endothelium. Possible role in the inactivation of thrombin by antithrombin III
Lollar P, Owen WG. Clearance of thrombin from circulation in rabbits by high-affinity binding sites on endothelium. Possible role in the inactivation of thrombin by antithrombin III. J Clin Invest 1980; 66: 1222-30.
